Skip to main content

Features

April 15, 2021
Robert Fox, MD, PhD, explains the three key symptomatic complaints among patients with Sjögren syndrome, including the impact of these symptoms on patient quality of life factors.
April 12, 2021
Following his presentation at IAS 2021, Dr Robert Fox spoke with ALN regarding the important takeaways from his presentation on Sjögren syndrome.
ALN
January 26, 2021
Behçet disease impacts multiorgan systems and can be a very isolating disorder. The American Behçet Disease Association discussed how it advocates and helps patients with Behçet disease.
ALN
December 10, 2020
Behçet disease, also known as Behçet syndrome, is rare in the United States. Delfin Santos, MD, discusses important clinical considerations and characteristics of this condition.
Gastro Learning Network
October 27, 2020

Researchers reveal enhanced understanding of monogenic inflammatory bowel disease is essential to improved outcomes.

Rheumatology Consultant
July 21, 2020
A 29-day-old girl was referred to a dermatology practice by a general pediatrics clinic after having been evaluated in the emergency department for a scattered erythematous eruption on her scalp, face, neck, legs, and abdomen for 4 days.
The Dermatologist
July 13, 2020
Kristi Hawley, DO, reviews the link between diabetes, obesity, and psoriasis, as well as treatment considerations for this patient population.
Gastro Learning Network
June 22, 2020
In this video, Bharati Kochar, MD, IBD specialist at the Massachusetts General Hospital in Boston, gives us a preview of her presentation for the Advances in Inflammatory Bowel Disease virtual 2020 regional meeting in Boston June 27.
ALN
November 12, 2019
While anti-tumor necrosis factor (TNF) inhibitors are effective treatments for patients with several inflammatory diseases, they may be associated with new onset psoriatic eruptions or paradoxical worsening of preexisting psoriatic skin disease. In an interview with The Dermatologist, Lourdes M. Perez-Chada, MD, MMSc, Sara Jiayang Li, BS, and Joseph F. Merola, MD, MMSc, discuss a novel treatment algorithm for managing patients treated with anti-TNF inhibitors who develop this adverse event.
Rheumatology Consultant
September 11, 2019

Approximately 1 year after beginning treatment with omalizumab, a 68-year-old man who had received a diagnosis of idiopathic urticaria and angioedema developed pain and swelling in the small joints of his hands and wrists.

Back to Top